BreatheSuite Inc., a Canadian connected respiratory health company, today announced that it has received 510(K) clearance from the U.S. Food and Drug Administration (FDA) for its BreatheSuite ...
The device is attached to the top of the canister of the patient’s inhaler and works together with the mobile app to monitor and provide feedback. The Food and Drug Administration has cleared the ...
Please provide your email address to receive an email when new articles are posted on . BreatheSuite announced that it received 510(k) clearance from the FDA for its Metered-Dose Inhaler V1 device, ...
With almost 30 million people under the age of 45 living with asthma in Europe, new 'smart inhalers' may provide better ways of treating the disease and help scientists understand what is driving this ...
LONDON--(BUSINESS WIRE)--The latest market research report by Technavio on the global smart inhaler technology market predicts a CAGR of over 51% during the period 2018-2022. The report segments the ...
LONDON (Reuters) - Makers of inhalers to treat asthma and chronic lung disease are racing to develop a new generation of smart devices with sensors to monitor if patients are using their puffers ...
Inhalers are used to treat chronic obstructive pulmonary disease (COPD), such as asthma, by delivering bronchodilator medication to the airway directly, without passing through the blood. COPD affects ...
DUBLIN--(BUSINESS WIRE)--The "Smart Inhalers Market to 2027 - Global Analysis and Forecasts by Product; Disorder; End User and Geography" report has been added to ResearchAndMarkets.com's offering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results